Best GLP-1 Provider for Adults With ADHD

Five programs compared on medication review, clinician access, nutrition support, what happens when you're late, and what actually arrives in the box.

By the Weight Loss Provider Guide Research Team Published August 17, 2026 · Last verified: August 17, 2026

Weight Loss Provider Guide is an independent comparison resource for GLP-1 telehealth providers. Some links on this page earn us a commission at no extra cost to you. Our top pick is not one of those links.

The best GLP-1 provider for adults with ADHD is Form Health. It's the only program we reviewed that publicly promises monthly video visits with both a clinician and a registered dietitian, and it says you can cancel at any time. Self-pay is $299 a month before medication. That price is the honest catch, and for a lot of people it's a dealbreaker.

So here are the other two doors. If insurance paperwork is what's stopped you before, Ro is the better fit — $39 for your first month, then as low as $74/month with an annual plan paid upfront, and they handle the coverage paperwork for you. If you want to pick your own clinician and keep the same one, Sesame starts at $59/month on an annual plan. Medication is billed separately at all three.

Now the part almost nobody tells you before you hand over a card. Four programs in this comparison can cost you money if you miss a term or cancellation cutoff. Some manufacturer-direct medication routes add a separate refill clock. One program can leave you paying for nine months you never used. One manufacturer offer can raise your next medication price by as much as $250 if you miss a 45-day window. We priced all of it out below, in a table, because a deadline you didn't know about is the most expensive thing on this page.

The short version

One thing to be clear about before you read further: none of these programs advertises a combined ADHD-and-GLP-1 service. Not one. We looked. So we did not rank them on ADHD expertise they don't claim to have. We ranked them on the things that actually decide whether this works for someone with ADHD — who reads your full medication list, how often you talk to a human, whether nutrition help is included, and how many deadlines the program hands you.

Your ADHD prescriber stays in the picture. That's not a limitation of these programs. That's just how it works.

Which GLP-1 provider is best for adults with ADHD?

Form Health is the strongest overall fit because its published care model includes monthly video visits with both a clinician and a registered dietitian, unlimited messaging, and FDA-approved weight-loss medication when appropriate, at $299 per month self-pay before medication and labs. Ro is the better choice for someone whose ADHD care is already stable and whose main barrier is insurance paperwork or medication access. Sesame is the better choice for someone who wants to choose a specific clinician and keep that person.

Here's why Form wins on this particular question.

Form's own FAQ page states the self-pay plan is $299 per month and covers your Form clinician visits, appointments with your Registered Dietitian, unlimited messaging, and access to the Form platform. Labs and medication are separate. That $299 fee is HSA/FSA eligible. Form also accepts most major private insurance and Medicare — and when it's covered, you pay a copay instead of a program fee, the way you would at any specialist's office. Its care team is led by a physician certified by the American Board of Obesity Medicine.

Three details matter more than the price tag:

1. A dietitian is included, not sold separately. Craig Surman, MD — who directs the Clinical and Research Program in Adult ADHD at Harvard Medical School — has said working with a nutritionist or dietitian makes healthy eating easier, and he noted that "Folks with ADHD generally have a hard time following through on independent homework." Every other program on this page essentially hands you homework.
2. There's no published cancellation deadline to miss. Form's own FAQ says you can cancel your membership at any time. Read the next section on late fees and you'll see how rare that is.
3. It expects you to have a regular doctor. Form's signup asks for active primary care. That means an outside prescriber is built into the model instead of ignored by it.

Who should pick Form Health

• Your medication list is long or complicated.
• Your eating is already inconsistent, and you want a professional helping with that part.
• You have insurance Form accepts, or the $299 works for you (remember: HSA/FSA eligible).
• You want FDA-approved medicine only.
• You've already tried a fast online program and it didn't stick.

Who should skip it

• You mainly need help getting insurance to pay.
• $299 a month is not happening.
• You don't want scheduled appointments on your calendar.
• You already have a dietitian and a doctor you like.

The honest catch

Form Health does not give you the cheapest path or same-day access, and $299 a month before medication is the highest care fee in this comparison. If price or speed is your top priority, Ro is the better program and you should use that door instead. But because Form skips the cheap-and-instant model, it can afford to put a weight-management clinician and a registered dietitian on video with you every single month — and publicly say you can cancel at any time. Fast programs can't do that math. That's the trade you're making.

Want a doctor and a dietitian, not a form and a prescription? Check whether Form Health is covered by your insurance and available in your state → We earn nothing from this link. We're recommending it anyway, because it's the answer to the question this page asks.

Can you take a GLP-1 with Adderall, Vyvanse, or other ADHD medicine?

Common ADHD medicines are not listed as blanket contraindications on the Wegovy or Zepbound labels. But that does not mean “nothing to watch.” GLP-1 medicines can delay stomach emptying, which may affect how an oral medicine is absorbed. The practical things to watch are appetite, blood pressure, heart rate, hydration, and any repeated change in how your ADHD medicine feels. Both prescribers need your full medication list.

This question changes based on the exact ADHD medicine and formulation you take. Here's the short version.

What delayed stomach emptying does and doesn't prove. It creates a real possibility that an oral pill may kick in at a different time. It does not prove your ADHD medicine will stop working. The current Wegovy prescribing information and Zepbound prescribing information warn that delayed gastric emptying can affect oral medicines. Neither label tells patients to stop ADHD treatment.

What a Johns Hopkins psychiatrist adds: David Goodman, MD, has explained that many ADHD medicines are made to release over time, so a delayed start does not automatically mean the medicine will fail. That is useful context. It is not a promise about your exact prescription.

Here's the part that's genuinely new, and it's the reason your medication class changes what to watch:

What your ADHD medicine class means for monitoring

That guanfacine row is the one almost every article on this topic misses. If you take guanfacine or clonidine, a program that actually reviews blood pressure and asks about hydration isn't a nice extra. It's the specific feature you're shopping for.

What we won't do here: tell you to move your dose earlier, switch formulations, split a pill, or take extra. Do not split, crush, open, or change an extended-release product unless the label for that exact product and the prescriber who manages it say you can.

One more thing about your two prescribers. Do not assume your GLP-1 clinician and ADHD prescriber will talk to each other unless you ask, share records, or sign a release. The single most useful thing you can do is give each one the complete list — every prescription, every over-the-counter product, every supplement — and say out loud who is watching what.

No offer here. You haven't decided anything yet.

Is it safe to take two things that both kill your appetite?

This is one of the most practical risks in the combination, and it deserves a straight answer: stimulants can reduce appetite, GLP-1 medicines reduce appetite, and together some people eat less than their body needs. That's not an automatic reason to avoid a GLP-1. It's the reason to pick a program with nutrition support and a person you can actually reach, and to tell your clinician up front that your appetite is already low.

Understood's expert-reviewed article on GLP-1s and ADHD puts the main problem plainly: when both medicines lower appetite, some people may not feel the need to eat enough. Low blood sugar is a separate concern and is especially important for people who also use insulin or a sulfonylurea; it should not be presented as a routine result of combining a stimulant with a GLP-1.

People say the same thing in their own words. In adult ADHD forums, people describe a stomach that is physically empty while the signal to stop and eat barely gets their attention. Others ask for foods or routines that help them get enough nutrition when hunger is no longer doing the reminding.

(Those are forum posts. They tell us how people actually talk about this. They aren't medical evidence.)

Nobody is answering that question for them. That's the gap.

What "enough support" actually looks like

We're not going to hand you calorie targets or gram counts. That's between you and a clinician who knows your history. What we can tell you is what to look for in a program:

• A registered dietitian included in the price. Form Health includes monthly dietitian video visits in its $299 self-pay plan. WeightWatchers says registered dietitians are part of its broader care team, but a one-on-one RD visit is a separate service: the current cash price is $99 for one visit or as low as $49 per visit in a 12-visit bundle, and qualifying insurance may reduce that cost. Ro's Body membership does not publicly include a dedicated dietitian. That's a real difference, and for this specific concern it's one of the biggest on the page.
• A way to reach a human the same week. Not just a chatbot. Not just a ticket with no clinical owner.
• Someone who asked about your appetite before prescribing — not just whether you take medications, but whether you're currently able to eat.
• A live visit option if something changes after a dose increase.

Say this at your first visit

Copy it if you want:

"I take [medication] for ADHD. My appetite is already low during the day. I want to know what you'd want me to watch for, and who I should message if I'm struggling to eat."

A good clinician will have an answer ready. If the answer is vague, that tells you something about the program.

Not sure which level of support you actually need? Use our free GLP-1 path finder → It helps you sort the care model, insurance route, budget, and reminder load that fit you. It does not decide whether a medicine is safe for you. Only a licensed clinician who knows your history can do that.

Do GLP-1 medicines actually help ADHD?

No GLP-1 medicine is established as an ADHD treatment. No published clinical trial has shown that a GLP-1 treats ADHD. Some people report that a GLP-1 quieted their constant thoughts about food and that daily life got easier as a result, but that is not the same as treating attention, impulsivity, or executive function. Treat a GLP-1 as weight treatment and keep treating ADHD as ADHD.

We're putting this section high on the page because if you came here hoping a weight-loss shot or pill would fix your focus, you deserve to know before you spend money.

What the experts say. David Goodman, MD, of the Johns Hopkins University School of Medicine has explained that the known GLP-1 pathways do not map neatly onto the brain systems behind ADHD's core attention and executive-function problems. He has also said the evidence is far too early for routine clinical use as an ADHD treatment. As of our August 17, 2026 review, we found no published clinical trial showing that a GLP-1 improves ADHD symptoms.

What people genuinely experience. "Food noise" is the repeated mental pull of thinking about food, planning the next thing to eat, and not being able to shift your attention off it. When that quiets down, life can get easier. Craig Surman, MD, offered a useful analogy: fewer hunger-driven distractions can feel like putting on headphones. That's a plausible knock-on effect. It is not the same as treating ADHD.

And here's the finding that almost nobody in this corner of the internet has reported.

In January 2026, psychiatry researchers at the University of Miami Miller School of Medicine published a chart review of 226 adults prescribed GLP-1 medicines between January 2021 and April 2024 (Sa B, Maristany A, Subramaniam A, et al., Journal of Psychiatric Research, 2026;195:92–96). Most patients stayed psychiatrically stable — 73.6% of those with major depression and 78.5% of those with generalized anxiety. New diagnoses also appeared in a subset, and ADHD had the shortest reported average time to onset: 7.8 months.

Read that carefully, because it cuts both ways. It does not prove a GLP-1 causes ADHD symptoms. A chart review cannot prove that, and the published abstract does not give the size of the ADHD subgroup. It also does not show that GLP-1 medicines treat ADHD. It shows why confident social-media claims are running ahead of the evidence.

So: two honest sentences you won't find on a page that's trying to sell you something.

Some people feel better when food thoughts get quieter. That does not make the medicine an ADHD treatment. One observational study recorded new ADHD diagnoses during follow-up. That does not prove the medicine caused them.

What makes a GLP-1 provider a better fit if you have ADHD?

A better-fit program reviews your complete medication list before prescribing, gives you access to a real clinician after the prescription is written, includes enough nutrition and monitoring support to catch problems early, and hands you as few deadlines as possible. An "ADHD-friendly" label isn't required. A prescription-only program with no follow-up is a weak fit when appetite, routines, and oral-medicine timing are already on your mind.

This is where we can stop guessing and use actual data — and it's the reason our ranking looks different from every other page on this topic.

First, so you know you're not an unusual case that nobody planned for: a 2016 review in the American Journal of Psychiatry pooled 42 studies covering 48,161 people with ADHD and 679,975 comparison subjects. It found that adults with ADHD had about 1.55 times the odds of obesity (Cortese S, Moreira-Maia CR, St Fleur D, et al. 2016;173:34–43). That's not a footnote population. That's millions of people, and almost none of the marketing in this category is written for them.

The research nobody applies to this decision

• In a study of 4,011 patients with ADHD, average medication adherence was 56%, and only 27.5% hit the standard 80% threshold. The factor associated with better adherence? More behavioral-health and primary-care visits. More contact with clinicians, more sticking with treatment.
• A review of the ADHD adherence literature found rates of stopping treatment or not taking medication as prescribed ranging from 13.2% to 64%, and pointed to disorganization and planning problems as common reasons.
• Forgetfulness belongs in that same pattern. A program that relies on you to remember every refill, renewal, message, and dose without outside prompts is asking the symptom to manage the treatment.
• Across chronic medicines generally, a meta-analysis found that average taking adherence was 6.7 percentage points lower for twice-daily dosing, 13.5 points lower for three-times-daily dosing, and 19.2 points lower for four-times-daily dosing compared with once-daily dosing.

Put those four findings next to each other and you get a conclusion that is almost the exact opposite of how GLP-1 programs are marketed:

Our conclusion: the fastest, cheapest, most hands-off program can be the worst structural fit for the person most likely to drift away from treatment.

"Sign up in five minutes, no appointments, no phone calls" sounds like it was designed for an ADHD brain. Actually, it removes the one thing the research links to follow-through: a person who expects to see you again. That is our editorial framework, not a clinical trial comparing these five programs in adults with ADHD.

The seven things we scored

1. Full medication reconciliation. Not "we ask about current medications" on a form. Does a clinician read it, and can they see the formulation and prescriber?
2. Live clinician access. Is there a video visit before prescribing? Can you get one later? Can you keep the same person?
3. Nutrition safeguards. Is a registered dietitian included, an add-on, or absent?
4. Monitoring. Blood pressure, heart rate, labs when appropriate, and a clear path when something changes.
5. Structure support. Reminders, refill alerts, tracking, workshops, community — the external scaffolding that does the remembering for you.
6. Coordination. Can you get your notes? Can another clinician contact the team?
7. Deadline load. How many dates can you miss, and what does each one cost?

That last one is ours. We haven't seen another comparison in this category score it. It turned out to be the most decision-changing column in the whole dataset.

How the 5 best GLP-1 providers for adults with ADHD compare

Form Health documents the deepest care model, with monthly video visits with both a clinician and a registered dietitian. Ro offers the clearest path to FDA-approved medication with insurance help at a lower care fee. Sesame lets you browse and choose your own clinician. WW Med+ has the most structure and community support but its public offers lock you into a term. Embody has the lowest published bundled price in the compounded-injection lane.

Every cell below was checked against the provider's own public pages on August 17, 2026. Where a provider doesn't publish something, we wrote "Not published" — not "no." Absence of an answer is not the same as a bad answer, and we won't pretend otherwise.

Provider-stated versus independently checked

A note on Ro and video visits: Ro publicly promises licensed-provider review and ongoing support. It does not publicly promise that every first evaluation is a live video call. If a human conversation before prescribing is your line in the sand, ask Ro before paying — or use Sesame, where a video visit with the provider you choose is part of the published program.

A note on Sesame: Sesame also runs a separate ADHD service. Its current ADHD page says online providers prescribe non-stimulant options, not controlled stimulants such as Adderall, Vyvanse, Ritalin, or Concerta. Having both services on one platform does not mean one clinician manages both treatment plans. Keep your stimulant prescriber.

Find yourself in this table

That last row is not a formality. If you are already struggling to eat, adding a second appetite reducer is a conversation, not a checkout.

Have insurance and want brand-name medicine without fighting the paperwork yourself? Start Ro's free GLP-1 insurance coverage check → It's free, it happens before you pay anything, and your $39 first month is refunded if you're not eligible for GLP-1s. Ro currently lists Wegovy pill, Foundayo, Wegovy pen, and Zepbound KwikPen cash routes, and its insurance team checks coverage for Ozempic, Wegovy, and Zepbound autoinjector pens. We do not earn a commission from this link.

Want to read clinician profiles and choose the person who'll manage this? See which Sesame providers are available in your state and what they charge → Sesame shows the program and provider details before you start, and ongoing video care is part of the published service. We do not earn a commission from this link.

Which GLP-1 is easiest to stay on if you forget things?

Weekly injections give you more room than a daily pill, but the exact rule depends on the product. For a missed Wegovy injection, take it only when the next scheduled dose is more than 48 hours away; otherwise skip it. Zepbound can be taken within 4 days (96 hours) of the missed dose. A missed Wegovy tablet is skipped until the next day. A missed Foundayo tablet is taken as soon as possible without doubling.

This is the table we most wish someone had shown us. It uses the current FDA prescribing instructions, not an old rule copied from a blog.

Three things follow from this that change what you should buy:

1. You are allowed to move your injection day. Almost nobody tells patients this. Zepbound needs at least 3 days (72 hours) between doses. Wegovy's day can be moved as long as the prior dose was at least 2 days earlier. If Sunday morning is the only time you reliably remember anything, ask your prescriber about moving your dose to Sunday. It's in the instructions, not a hack.

2. The pill is not automatically the easy option. A daily tablet means 365 chances a year to forget instead of 52. Wegovy tablets also carry a morning ritual: empty stomach, no more than 4 ounces of plain water, then wait at least 30 minutes before food, other drinks, or any other oral medicine. If you take a morning ADHD pill, that instruction forces a timing conversation with your prescriber.

3. Foundayo is the oral GLP-1 without a food-and-water ritual. Foundayo (orforglipron), FDA-approved April 1, 2026, is taken once daily with or without food. Swallow it whole. If you miss one dose, take it as soon as possible and do not double. Its label still carries a thyroid C-cell-tumor warning and a contraindication for a personal or family history of medullary thyroid carcinoma or MEN 2. Ro, Sesame, and WW Med+ currently list it.

Storage matters too, and the windows are different for every product — a Wegovy pen and a Zepbound device do not get the same amount of time out of the fridge. We keep a separate table sourced to the official labels: GLP-1 medication storage temperature guide.

What being late actually costs you at each program

Late fees in this category are rarely called late fees. They show up as cancellation cutoffs, prepaid terms, and refill windows. In this comparison they range from nothing at Form Health to paying through the rest of a 6- or 12-month term, or losing a manufacturer offer that can raise the next Zepbound fill by as much as $250.

This is the section we built this page for. Read it before you enter a card number anywhere.

Two things to say about that table.

First, the 45-day figures are no longer a mystery. Lilly's current public terms pin them down: Zepbound's late difference is $50 at 7.5 mg and $250 at 10, 12.5, or 15 mg. Foundayo's late difference is $50 at 14.5 or 17.2 mg. Offers can change, so check the live terms again before relying on them.

Second — and this is the honest editorial point — these terms are not aimed at people with ADHD. They're standard subscription and manufacturer-offer rules. But they land hardest on exactly the people least able to absorb them. A 48-hour cancellation cutoff, a five-day cutoff, and a 45-day refill clock are, functionally, a tax on time blindness.

The two-minute fix

You don't have to avoid these programs. You have to beat the dates.

1. Right now, before you sign up anywhere: put a repeating phone alert 5 days before your billing date, labeled with the program name and the words "cancel by."
2. Add a second alert on refill day if your medication route has a refill window.
3. Screenshot every cancellation confirmation. That screenshot is your proof if the billing date and your memory disagree later.

Do those three things and most of the table above becomes avoidable. That's the point.

If a deadline you might miss is the thing that's kept you from starting: See Form Health's terms and check availability in your state → It is the only program here whose public FAQ says you can cancel at any time, with no published 48-hour or five-day cutoff. We make nothing if you use this link — we're pointing at it because it directly answers the fear.

What actually arrives in the box, and why it matters

The device matters because the steps are not the same. A single-dose pen gives a preset dose. A branded single-dose vial still requires a syringe, but it does not ask you to calculate a fraction of a multi-dose vial. A compounded multi-dose vial may require you to match milligrams, milliliters, concentration, and syringe units. The FDA's reports of 5-to-20-times dosing errors involved compounded semaglutide dispensed in multi-dose vials — not every vial and not every branded product.

Ask one question before you pay: what will arrive, and will I have to do math with it?

A poison-center case series in the clinical literature put the multi-dose-vial problem more bluntly, noting that vials lack the preset safety features of manufactured pens and can allow large dosing errors. The FDA's own alert gives the clearest documented example: some patients told to draw 5 units drew 50.

And here's the part that catches people off guard: brand-name Zepbound now comes in more than one presentation. The current label lists a vial, a prefilled single-dose pen, and a single-patient-use KwikPen. Current cash-pay pages from Ro and Sesame list the KwikPen, while other routes also list vials. Do not assume the logo tells you the device. Confirm the exact presentation on your order.

None of that is a claim about ADHD. It's what the reports and labels describe about human beings, devices, and numbers. But if your attention reliably wanders during small repetitive tasks with measurements in them, you are allowed to weigh that when you choose a format — and you're allowed to ask a program point-blank whether it will ship a pen, a single-dose vial, a prefilled syringe, or a multi-dose vial, and what the exact written dose instruction will say.

The FDA also notes that some products sold by compounders use salt forms — semaglutide sodium or semaglutide acetate — which are different active ingredients from those in the approved drugs. That's another fair question to ask before you pay.

What will this actually cost me?

Care fees in this comparison run from $59/month on Sesame's annual commitment to $299/month for Form Health self-pay, before medication. Embody is different because its published price bundles the compounded prescription route. The cheapest membership is not automatically the cheapest total, because medication, labs, insurance coverage, prepayment, and commitment terms all move the final number.

These are simple arithmetic illustrations of published program fees as of August 17, 2026. They are not total treatment-cost estimates. Re-check every price, amount due today, renewal date, and commitment before you enroll.

Three cost traps worth knowing

"As low as $74/month" is not the same as being billed $74 this month. Ro's annual price is a prepaid $888 charge after the $39 first month. Sesame's $59 price is tied to a $708 annual commitment. Look at the amount due today at checkout.

Two bills, not one. Every FDA-approved GLP-1 program here bills the program and the medicine separately. The "$39" or "$25" in an ad is the program. Ro and Sesame currently list starting cash prices of $149 for Wegovy tablets and Foundayo, $199 for a Wegovy pen route, and $299 for a Zepbound KwikPen starting dose. Higher doses can cost more. With commercial insurance that covers your GLP-1, the medicine may drop to a copay.

The membership can be the cheap part or the whole point. If your insurance covers the medicine, a program that fights your insurer for you can pay for itself in one approval. If your plan excludes weight-loss drugs, you're comparing total cash outlay, and a bundled compounded program will usually be lower — with the trade-offs described above.

If your budget is the hard limit and you are open to the compounded lane: Read our full Embody review before you check the current offer → It covers the current pricing tiers, five-day cancellation rule, inactive gum listings, and the details Embody still does not publish. We may earn a commission if you enroll through links on that review, at no extra cost to you.

What are the real drawbacks of each one?

Every option here has a limitation that will matter to somebody: Form Health is expensive for self-pay, Ro does not include a dedicated dietitian or guarantee a live first evaluation, Sesame bills medicine separately and its annual price requires a commitment, WW Med+ locks its public offers into a term and charges separately for one-on-one RD visits, and Embody is in the compounded lane with important details that are not known until prescription and fulfillment. The right pick depends on which limitation you can live with.

Form Health — $299/month self-pay before medication and labs. It does not manage your ADHD treatment. If cost is the barrier, go to Ro or Sesame.

Ro — No dedicated registered dietitian is publicly included in the Body membership, and a live first visit is not publicly guaranteed. If monthly nutrition care or a guaranteed video evaluation is your priority, Form Health or Sesame is the better fit.

Sesame — The $59 rate requires an annual commitment, medication is separate, and the price and stock depend on the prescription, pharmacy, and insurance route. Sesame can send a prescription to a local pharmacy or home-delivery route, but you still need to confirm the final medicine price and format. Its separate ADHD service does not prescribe controlled stimulants. If you want a more centralized insurance-and-shipping path, Ro may be simpler.

WW Med+ — The commitment. The current public offer is $74/month on a 12-month term or $84/month on a 6-month term after the $25 first month. Canceling stops the next term; it does not erase the term you bought. One-on-one registered-dietitian visits are available, but they are a separate service rather than a monthly visit built into the Med+ fee.

Embody — Compounded medicines are not FDA-approved; the FDA does not review them for safety, effectiveness, or quality before they're marketed. Embody's current active terms list injections, not the old gum program. They also say the final charge may vary by prescribed medication and pharmacy, and cancellation must be submitted at least five days before the prescription period ends. If you want FDA-approved medicine or the cleanest device and pharmacy trail, use Form Health, Ro, Sesame, or WW Med+.

Who should close this page

• You want a GLP-1 because you read it helps ADHD. It isn't an ADHD treatment. Go back and read that section.
• You're already not eating. Call your prescriber, not a telehealth checkout.
• You have symptoms or a history that may make GLP-1 treatment unsafe. Read our GLP-1 contraindications guide and talk to a clinician before shopping.
• You are not sure you meet the usual treatment criteria. Start with GLP-1 eligibility, not a provider checkout.
• You want a prescription with zero follow-up, as cheaply as possible. We can't recommend that combination for someone managing two medicines from two prescribers. If price is genuinely the only variable, use our general GLP-1 provider comparison instead of this page, and go in knowing the trade.

Which popular programs did not make our list, and why?

Two well-known names were left out of our lead group because the FDA issued them warning letters on February 20, 2026 over false or misleading claims about compounded GLP-1 products: MEDVi (letter #721455) and Ivim (letter #721816). The letters concern website and labeling claims. They do not report contamination or patient injury, and a warning letter is not a final agency action. We're disclosing them because this page is about whether a company clearly tells you what is in the box and who made it.

Here's what actually happened, in plain terms.

On March 3, 2026, the FDA announced warning letters to 30 telehealth companies. The agency said the cited marketing could make compounded products look the same as FDA-approved drugs or make the telehealth brand look like the compounder when it was not.

In MEDVi's letter, the FDA said the pictured labels identified “MEDVi,” suggesting MEDVi compounded the drugs when it did not. The letter also cited “same active ingredient” claims that the agency said implied FDA approval or safety-and-effectiveness review that compounded products had not received.

The Ivim letter cited the same core labeling problem: the pictured compounded products identified Ivim in a way the FDA said suggested Ivim was the compounder when it was not.

Fair context, because fairness matters here: FDA warning letters put a company on notice of the agency's concerns and ask for correction. They are not a court judgment and not a final agency action. Neither of these letters said the medicine was contaminated or that a patient was harmed by it.

Why it still changes our ranking for this page. This entire comparison is about picking a program that will accurately handle information — your medication list, your dose, and what you're actually taking. Recommending a company the FDA cited for inaccurate or misleading product presentation, on this specific page, would contradict the page's own argument. So they're disclosed here instead of ranked above.

The back-end test almost nobody runs

Here's something we found while checking this, and it's the single most useful thing in this section.

The brand on the website may not be the medical group providing care or the pharmacy making and dispensing the medicine. The MEDVi letter is a direct example: FDA said the pictured label suggested MEDVi was the compounder when it was not. Embody's current terms make the separation explicit: Modern Metabolic Medicine operates the platform, independent medical groups and clinicians provide care, and independent pharmacies dispense prescriptions.

That model is not automatically bad. It does mean switching brands does not prove you switched the clinical group, pharmacy, or formulation. You may have changed the logo and price while part of the back end stayed the same.

So ask two questions before you pay: “Which medical group provides my clinician?” and “Which pharmacy will fill this prescription?” A legitimate program should be able to answer both before the medicine ships. Those answers tell you more than the logo does.

How did we check all this?

We compared the same criteria across every program using each provider's own public pricing, program, and terms pages, plus FDA records, current FDA drug labels, manufacturer offer terms, and published research. Provider claims, regulatory facts, independent research, anecdotes, and our own editorial conclusions are labeled separately. We did not enroll as patients, and we did not test any medication.

Our source order, strongest first: FDA labels and regulatory records → manufacturer offer terms → the provider's official pricing and terms pages → peer-reviewed research → provider-hosted testimonials → public forums, which we use only to learn how people describe the problem, never as medical evidence.

What we actually verified

Verified on August 17, 2026:

• Form Health's monthly clinician-and-dietitian video model, $299 self-pay fee, HSA/FSA eligibility, medication-and-lab separation, PCP requirement, insurance language, and cancel-any-time statement, from Form Health's FAQ
• Ro's $39 first month, $74/$89/$99/$149 membership ladder, current FDA-approved cash formulary, and insurance-check route, from Ro's pricing page
• Sesame's $59 annual starting price, $99 every-28-days option, provider-choice model, video care, labs, pharmacy options, and 48-hour cancellation cutoff, from Sesame's program page and terms
• WeightWatchers' $25/$74/$84 public offer, 6- and 12-month auto-renewal language, behavior tools, and separate one-on-one dietitian pricing, from WW Med+ and WW's dietitian page
• Embody's active $79 semaglutide and $129 tirzepatide monthly prices, lower long-term tiers, five-day cancellation rule, inactive gum programs, independent clinical/pharmacy structure, and price-variability language, from Embody's current terms
• FDA warning letters #721455 (MEDVi) and #721816 (Ivim), both dated February 20, 2026
• The FDA's July 2024 alert on 5-to-20-times dosing errors involving compounded semaglutide in multi-dose vials
• Current label instructions for Wegovy injection, Wegovy tablets, Zepbound, and Foundayo, including missed-dose, day-change, and tablet-timing rules
• Lilly's current 45-day Zepbound and Foundayo purchase-offer terms and the exact regular prices that apply when the offer is lost
• The 42-study ADHD-and-obesity meta-analysis, the 4,011-patient adherence study, and the 226-patient psychiatric chart review discussed above

What we did not verify, and won't pretend to:

• That any program specializes in adults with ADHD. None claims to.
• That any specific program will coordinate directly with your ADHD prescriber.
• Your eligibility, your insurance coverage, or your out-of-pocket medication cost.
• Every state's current availability.
• That any testimonial or forum result is typical.
• The exact clinician, medical group, pharmacy, concentration, or device you will receive until the provider confirms it for your order.

Where our money comes from

Weight Loss Provider Guide is an independent comparison resource for GLP-1 telehealth providers. We earn a commission when readers use some links on this page, at no extra cost to them. On this page, Embody is a partner. Form Health, Ro, Sesame, and WeightWatchers are not. Our top pick is Form Health. We'd rather tell you that than hide the economics — the program we put first pays us nothing, while the lowest-ranked program in the table is the one that can pay us.

What patients say about the service

"My doctors are very attentive and hands on, available whenever I need them." — Mary D., testimonial published on Form Health's website.

"The doctor they paired me with was kind, empathetic, [and] explained everything thoroughly." — Lisa, testimonial published by Sesame.

Both are provider-published reviews of the service experience — how people were treated and how easy it was to reach someone. Neither is evidence of medical results, and results vary from person to person.

Public discussions show both sides of the medication-timing question: some people say a stimulant felt slower or weaker after starting a GLP-1; others say they noticed no meaningful change or that an early difference settled down. Those reports are useful for knowing what to ask about. They are not proof of a universal interaction.

Update log

• August 17, 2026 — Page published. Provider prices and terms verified; Sesame cancellation corrected to 48 hours; Embody corrected to current injection-only pricing and five-day cancellation terms; current FDA missed-dose rules and exact 45-day manufacturer prices added.

What should you ask before you pay?

Ask who reads your ADHD medication list, who handles it if your daily functioning changes, how fast you can reach a person, and exactly what the displayed fee covers. A legitimate program can answer all four without claiming a GLP-1 treats ADHD.

Copy this into a chat window or read it on the phone. It takes about four minutes, and it can keep a missed term or refill window from costing you hundreds of dollars.

"I'm looking at your weight program and I already take medication for ADHD. Before I sign up:

1. Will a clinician read my full medication list — including my ADHD prescription and its formulation — before deciding whether treatment is appropriate?
2. Which medical group provides that clinician, and which pharmacy will fill the prescription?
3. Is my first visit a live video visit, or a review of my form?
4. What should I do if my oral medication starts feeling different after I start?
5. Is a registered dietitian included in the price, part of the care team, or a separate charge?
6. Will you review my blood pressure and heart rate?
7. Will I get a pen, a single-dose vial, a prefilled syringe, or a multi-dose vial? What will the written dose instruction say?
8. What is charged today, what renews, and what is the exact cancellation deadline?"

If they dodge question 2 or question 8, you've learned what you needed to know.

Know what level of care you need but not who has it? Get your personalized GLP-1 path → It sorts the next step by insurance, support needs, budget, medication format, and reminder load. It does not give a medical eligibility verdict.

Frequently asked questions

What is the best GLP-1 provider for adults with ADHD? Form Health is the best overall care model because it includes monthly video visits with both a clinician and a registered dietitian, unlimited messaging, and a public cancel-any-time policy, at $299/month self-pay before medication and labs. Ro is the better choice at a lower care fee when insurance help and FDA-approved medication access are your main needs. Sesame is the better choice when you want to choose a specific clinician.

Can I take Wegovy with Adderall? Wegovy's label does not name Adderall as a blanket contraindication. Wegovy can delay stomach emptying and may affect oral medicines. Tell both prescribers, and report any repeated change to the one who prescribes your Adderall.

Can I take Zepbound with Vyvanse? Zepbound's label warns that delayed stomach emptying can affect oral medicines. That is a reason to watch and report a repeated change, not proof Vyvanse will stop working. Do not change timing or dose on your own.

Will a GLP-1 make my ADHD medicine less effective? Some patients report their medicine feels slower or weaker. Those reports do not establish a universal interaction. Write down what changed, how often it happened, and bring it to your ADHD prescriber.

Do GLP-1 medicines treat ADHD? No GLP-1 is established as an ADHD treatment, and no published clinical trial has shown one treats ADHD. A 2026 chart review of 226 patients recorded new ADHD diagnoses during GLP-1 treatment and reported a 7.8-month average time to onset in that subgroup, but it cannot prove the medicine caused them.

Which GLP-1 is best if I forget doses? Wegovy injection can be taken after a missed dose only when the next scheduled dose is more than 48 hours away. Zepbound allows 4 days. A missed Wegovy tablet is skipped until the next day. A missed Foundayo tablet is taken as soon as possible without doubling. Ask your prescriber about moving a weekly injection to the day you will actually remember.

What if my stimulant already kills my appetite? Say that at your first visit, before a prescription is written. It does not automatically disqualify you, but it makes nutrition support and reachable follow-up the features you should be shopping for. If you're already regularly unable to eat, talk to your prescriber before signing up for anything.

Is the daily pill easier than the weekly shot? Not necessarily. A daily pill means 365 chances a year to forget instead of 52. Wegovy tablets require an empty stomach, no more than 4 ounces of water, and a 30-minute wait before food, drinks, or other oral medicines. Foundayo is taken with or without food and has no water ritual.

Can one telehealth company prescribe both my GLP-1 and my ADHD medicine? Some platforms run separate weight and mental-health services, but that does not mean one clinician coordinates both plans. Sesame's online ADHD service, for example, lists non-stimulant treatment and says it does not prescribe controlled stimulants such as Adderall or Vyvanse. Assume you're keeping your current ADHD prescriber unless a clinician tells you otherwise.

Is compounded medication a bad idea if I have ADHD? ADHD does not make compounded medicine right or wrong. Two facts should shape the decision: compounded drugs are not FDA-approved, so the agency does not review their safety, effectiveness, or quality before marketing; and the FDA has published reports of 5-to-20-times dosing errors involving compounded semaglutide in multi-dose vials. If you choose that lane, ask for the pharmacy, formulation, concentration, device, syringe size, and written dose instruction in the same units you will measure.

Which is cheapest? Sesame's annual commitment at $59/month is the lowest care fee among the FDA-approved program options here. Embody's published compounded semaglutide program starts at $79/month with medicine bundled. But medication is billed separately at every FDA-approved program, so the lowest care fee is often not the lowest total.

How do I cancel, and when? Form Health says any time. Ro's monthly membership can be canceled, while prepaid plans are already paid. Sesame requires cancellation at least 48 hours before renewal. WW Med+ cancellation stops the next term, not the current 6- or 12-month commitment. Embody's current terms require at least five days before the end of the prescription period. Set a phone alert five days before your billing date on day one.

Do I need labs before starting? It depends on your history and the program. Sesame includes lab work at Quest in most states but lists state exceptions. Form Health bills labs through insurance or separately. Compare whether labs are included, ordered when clinically appropriate, or billed to you — rather than assuming everyone needs the same panel.

Should I tell my psychiatrist or ADHD prescriber? Yes. Something like: "I'm starting [medication] for weight on [date]. Here's my dose schedule. What do you want me to watch for, and when should I message you?" Bring the exact product and formulation, not just the words “GLP-1.”

If you take one thing from this page

The program that asks the least of you up front is usually the one that asks the most of you later — in deadlines, in remembering, in doing the math yourself. The research on ADHD and medication says the opposite is what works: more contact with a real clinician, not less.

So pick the level of support you actually need, put two alerts in your phone before you enter a card, and tell both of your prescribers everything. That's the whole strategy.

Still not sure which GLP-1 program is right for you? Use our free path finder.

This page is information, not medical advice. It cannot tell you whether a GLP-1 medicine is safe or appropriate for you — only a licensed clinician who knows your history can do that. Compounded medications are not FDA-approved; the FDA does not review them for safety, effectiveness, or quality before they are marketed. Prices, program features, and availability change often. Everything here was verified on the date shown at the top, and we re-check pricing monthly.